Indian Drugmaker To Produce 200 Million Doses Of Russian Sputnik V COVID Vaccine
Bengaluru-based drugmaker Stelis Biopharma will produce 200 million doses of Russia’s Sputnik V coronavirus vaccine. The Russian Direct Investment Fund (RDIF), which backed the development of Sputnik V, said on ...










![[Watch] Countdown Begins In India, But Here’s How Australia & New Zealand Welcome 2026](https://assets.odishabytes.com/wp-content/uploads/2025/12/new-year.webp)

